Noncommunicable Diseases, Rehabilitation and Disability
We are responsible for leading, coordinating and monitoring global action to cover additional people with health services, medicines, vaccines, diagnostic and health technologies for the prevention, screening, early diagnosis and appropriate treatment of cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. We aim to advance health equity for persons with disabilities, we have a focus on sensory impairments and bring together the work on rehabilitation from across the departments and from the 3 levels of the organization.

Oral health programme

The main oral diseases and conditions are estimated to affect 3.5 billion people globally, even though these diseases are largely preventable. Oral diseases and conditions share risk factors with other major NCDs (cancer, cardiovascular diseases, chronic respiratory diseases, and diabetes), including all forms of tobacco use, harmful alcohol consumption and intake of free sugars. Across the life course, oral diseases and conditions disproportionately affect the poor, vulnerable and disadvantaged members of societies.

WHO's oral health work aligns with other programme areas within the Management of Noncommunicable Diseases (MND) unit through focusing on strengthening cost-effective population-wide oral health promotion and oral health care within the primary health care system to achieve UHC for oral health by 2030.

Highlight

Related fact sheet

WHO global oral health meeting: Universal health coverage for oral health by 2030

Featured publication

Resolution on oral health (WHA74.5) and its mandates

WHO global oral health status report

Related events

Universal health coverage for oral health

Cost-effective interventions on oral health

The recent World Health Assembly resolution WHA 74.5 on oral health requested the WHO Director-General to develop “best buys” interventions on oral health, as part of an updated Appendix 3 of the WHO Global action plan on the prevention and control of NCDs and integrated into the WHO Universal health coverage (UHC) Intervention Compendium. 

As part of the 2022 update of Appendix 3 of the GAP-NCD, 2 interventions relating to oral cancer screening and sugar-sweetened beverage (SSB) taxation incorporate oral health into the modelling. The update is due to be considered by the World Health Assembly in 2023.

Work is ongoing to develop other models for cost-effective interventions on oral health. It is anticipated that these will be made available by 2024 and incorporated into future updates to Appendix 3 of the GAP-NCD.

Oral health and the UHC Compendium

As part of the wider WHO programme to develop the UHC Compendium, work is ongoing to further define and refine oral health actions to inform the oral health module of the compendium.

 

Related links

mOralHealth Programme

The WHO Oral health programme developed the mOralHealth programme as part of the Be He@lthy Be Mobile (BHBM) initiative with the International Telecommunication Union (ITU). The joint initiative BHBM guides delivery of disease prevention and management information through mobile technologies directly to specific target groups, including individuals, communities and health care professionals, to strengthen health systems.

In 2021, the “Mobile technologies for oral health: an implementation guide” was launched to promote global collaboration and advances in digital oral health. This guidance promotes oral health training for health workers, detecting oral health conditions, collecting epidemiological data, and monitoring the quality of patient care, all through mobile technologies. It aims to help countries develop and implement mOralHealth programmes to complement existing oral health programmes.

Related links

Mobile technologies for oral health: an implementation guide
Oral diseases affect about 3.5 billion people around the world. As well as impacting health, they also affect overall well-being and quality of life, especially...

The Minamata Convention on Mercury

The Minamata Convention on Mercury is a global treaty that entered into force in 2017 to protect human health and the environment from anthropogenic emissions and releases of mercury and mercury compounds. This Convention requires that countries that are parties to it implement measures to phase down the use of dental amalgam, a dental restorative material that is 50% mercury by weight.

In 2021, WHO organized an informal consultation with policy-makers in the field of dental public health to better understand progress in phasing down the use of dental amalgam at global, regional, and national levels. Following the consultation, the Report of the informal global WHO consultation with policymakers in dental public health, 2021: monitoring country progress in phasing down the use of dental amalgam was published. The consultation showed that effective, cost-effective and simple-to-use mercury-free alternatives to dental amalgam are increasingly available.

Furthermore, WHO published a series of briefing notes on Prevention and treatment of dental caries with mercury-free products and minimal intervention.

 

Related publications

Prevention and treatment of dental caries with mercury-free products and minimal intervention

This publication, the first in a series of briefing notes on oral health, focuses on the prevention and treatment of dental caries (tooth decay) with mercury-free...

Report of the informal global WHO consultation with policymakers in dental public health, 2021: monitoring country progress in phasing down the use of dental amalgam

Despite advances in modern dentistry, untreated dental caries in permanent teeth was reported as one the most prevalent conditions assessed in the 2019...

Noma

Noma is a necrotizing disease that destroys the mouth and face, affecting mostly children between the ages of 2 and 6 years who suffer from malnutrition and live in extreme poverty mostly in Africa, but has also been reported in other regions such as South-East Asia. Without prompt treatment, the acute phase of noma is devastating and is often fatal that 90% of patients die of sepsis or severe dehydration and malnutrition within two weeks of the onset of noma. Children who survive the disease are often left with serious aesthetic and functional consequences that can include disfigurement, impairments in breathing, swallowing, speaking and vision, and definitive mouth closure, which further leads to their social isolation, stigmatization, discrimination and to violations of their human rights.

The landmark resolution on oral health in 2021, adopted at the World Health Assembly (WHA74.5), requests the Director-General, inter alia, “to include noma in the planned WHO 2023 review process to consider the classification of additional diseases within the road map for neglected tropical diseases 2021–2030” since noma shares important characteristics with neglected tropical diseases (NTDs).